SK
Samarth Kulkarni (Chief Executive Officer) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in CRISPR Therapeutics AG (CRSP). The largest single filing was $5.2M of CRSP (90,000 sh across 3 lots, as filed), executed Jan 20. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
7
0 buys · 7 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$9.6M
shares × price, as filed
Last traded
Oct 19
Filed Oct 20
Median ADV $94.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $18.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
7 filings
Sector per market data · by filing · past 12 months
Most traded names
CRSPRecent filings
CRSPSALE
CRISPR Therapeutics AG
View filing →
$283K4,242 sh × $66.60
Exec Oct 14 2025
Filed Oct 15 2025 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $761K
13,081 sh × $58.15
Exec Aug 18 2025
Filed Aug 19 2025 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $414K
10,031 sh × $41.23
Exec Mar 21 2025
Filed Mar 24 2025 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $616K
14,435 sh across 2 lots
Exec Mar 11 2025
Filed Mar 12 2025 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $1.0M
18,360 sh × $55.21
Exec Feb 19 2025
Filed Feb 21 2025 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $1.0M
18,568 sh across 2 lots
Exec Feb 18 2025
Filed Feb 19 2025 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $826K
15,000 sh × $55.10
Exec Dec 2 2024
Filed Dec 4 2024 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $1.7M
30,000 sh across 2 lots
Exec Nov 11 2024
Filed Nov 13 2024 · 5:30 PM ET